Clyde Hosein insider trades: DENTSPLY SIRONA (XRAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Clyde reports to the SEC
and 1 more company
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | XRAY | ↑ Buy | 6,500 | $9.98 | $65K | Direct | Jun 16, 2026 (1d) |
| Jun 17, 2025 | CRDO | ↓ Sell | 2,000 | $78.49 | $157K | Direct | Jun 18, 2025 (1d) |
| Feb 19, 2021 | CREE | ↓ Sell | 13,816 | $125.48 | $1.7M | Direct | Feb 22, 2021 (3d) |
| May 1, 2017 | RNG | ↓ Sell | 200,000 | $32.08 | $6.4M | Direct | May 2, 2017 (1d) |
| Dec 14, 2016 | RNG | ↓ Sell | 159,813 | $22.40 | $3.6M | Direct | Dec 15, 2016 (1d) |
| May 23, 2016 | RNG | ↓ Sell | 2,409 | $18.27 | $44K | Direct | May 25, 2016 (2d) |
| Dec 14, 2015 | RNG | ↓ Sell | 82,682 | $24.65 | $2.0M | Direct | Dec 14, 2015 (0d) |
| Dec 3, 2015 | RNG | ↓ Sell | 25,000 | $23.42 | $586K | Direct | Dec 4, 2015 (1d) |
| Nov 24, 2015 | RNG | ↓ Sell | 26,007 | $22.57 | $587K | Direct | Nov 25, 2015 (1d) |
| Nov 18, 2015 | RNG | ↓ Sell | 100,000 | $22.34 | $2.2M | Direct | Nov 19, 2015 (1d) |
| Sep 4, 2014 | CREE | ↓ Sell | 5,000 | $44.73 | $224K | Direct | Sep 4, 2014 (0d) |
| Jun 7, 2013 | CREE | ↓ Sell | 5,000 | $62.87 | $314K | Direct | Jun 10, 2013 (3d) |
| May 13, 2010 | CREE | ↓ Sell | 18,750 | $78.90 | $1.5M | Direct | May 14, 2010 (1d) |
| Apr 9, 2010 | MRVL | ↓ Sell | 35,000 | $20.76 | $726K | Direct | Apr 13, 2010 (4d) |
| Oct 10, 2008 | MRVL | ↑ Buy | 10,000 | $6.85 | $69K | Direct | Oct 14, 2008 (4d) |
| May 20, 2008 | IDTI | ↓ Sell | 380 | $12.44 | $5K | Direct | May 22, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other XRAY insiders
Open-market trades in the last 12 months
About Clyde Hosein's insider trades
Clyde Hosein is a director at DENTSPLY SIRONA (XRAY). Since May 20, 2008, Clyde has reported 2 open-market purchases worth $133K and 14 sales worth $20.1M on SEC Form 4. In the last 12 months: 1 buy ($65K).
Their filings also include grants and awards (65 filings), option exercises (14 filings), conversions (6 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XRAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.